Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contamination
Irene GeorgiouiD, Sandra O’NeilliD, Colin Robinson, Fraser CunninghamiD, Sean N. O’ByrneiD, David W. GrayiD, Ian Hugh GilbertiD, Duncan E. ScottiD
Abstract
Different biochemical assays yield different rates of false positives than others either due to the nature of the enzyme, the technology associated with the assay, or properties of the compounds being screened. Ensuring that the right counter-screens are in place to identify false positives without wasting time and resources on them is of great importance. Herein we describe the results of a high throughput screen (HTS) against non-structural protein 3 (nsp3) protease PLPro, which resulted exclusively in false-positive hits. By triaging hit compounds through purification of metal chelating resin, we identified contamination by either copper or palladium as the most likely source of false positives from the library screening campaign. We then performed a systematic assessment of the vulnerability of nsp3 protease screening to metal contamination and evaluated common additives to combat the inhibitory effects of different metal salts. We further conducted a thorough survey of the literature reports of nsp3 HTS campaigns with a focus on the presence of additives and what metal susceptibility was likely, given the results of our work. We conclude that the majority of reported nsp3 screens are susceptible to copper contamination with a smaller proportion also potentially susceptible to palladium contamination.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 15th percentile
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of protease activity of Nsp3 from SARS-CoV-2 and its in vitro inhibition by nanobodies
L. Armstrong, S. M. Lange, … Y. Kulathu·bioRxiv·Dec 9, 2020
- Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp3 Papain-like Protease
L. A. Armstrong, R. Beale, … J. Zeng·bioRxiv·Apr 7, 2021
- A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
K.-Y. Chen, T. Krischuns, … N. Naffakh·bioRxiv·Dec 18, 2021
- Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19
K. Steuten, H. Kim, … M. Bogyo·bioRxiv·Nov 21, 2020
- A simplified cell-based assay to identify coronavirus 3CL protease inhibitors
S. J. Resnick, S. Iketani, … A. Chavez·bioRxiv·Aug 29, 2020
- Development of a fluorescence based, high-throughput SARS-CoV-2 3CLpro reporter assay
H. M. Froggatt, B. E. Heaton, N. S. Heaton·bioRxiv·Jun 24, 2020